February 21, 2018 - 8:00 am
February 23, 2018 - 5:00 pm
AddressKopanong Hotel and Conference Centre, Johannesburg, South Africa View map
AMC International welcomes you to attend the Drug Safety, Efficacy, Clinical Trials Conference, scheduled to take place on the 21st – 23rd February 2018 at Kopanong Hotel and Conference Centre, Benoni, Johannesburg, South Africa; focusing on “Examining the Pharmacovigilance Approaches and Innovations for Patient Risk Management in Africa”.
The field of Drug Safety, Efficacy & Clinical Trials also known as Pharmacovigilance, is growing rapidly and its development is making tremendous impacts in medical sciences and pharmaceuticals. Drug Safety, Efficacy & Clinical Trials emphasizes on how the importance and significance can be gauged by the fact that it has made huge advancements over the course of time and is continuing to influence Pharmacovigilance Researchers, Clinical Researchers, Clinical Trials & Drug Safety Associations, and various sectors.
The Conference will disseminate new insights into the current issues and associated challenges impacting drug safety, efficacy and clinical trials management focusing primarily on drug products throughout all phases of development and marketed use. Top pharmaceutical and regulatory representatives who are experts in their field will discuss the current regulatory framework for pharmacovigilance in global regions, operational challenges of implementing global benefit-risk analyses and risk management plans, new clinical trials, and the role of epidemiology in safety analysis.
Why Attend Drug Safety, Efficacy & Clinical Trials Conference 2017?
With industry professionals from around Africa focused on learning about Pharmacovigilance and its advances; this is your best opportunity to reach the largest gathering of participants from the Pharmacovigilance community. The event will be in a variety of formats including keynote presentations, case studies, interactive group debates and Q&A sessions. Renowned speakers will bring the most recent techniques, developments, and the newest updates in Drug Safety, Efficacy & Clinical Trials.
Who Should Attend:
Pharmacovigilance Researchers, Clinical Research Organisations, Regulatory Agencies, Clinical Research Coordinators, Clinical Trial Project Managers, Heads of Drug Safety, Hospital CEOs, Directors & Managers, Heads of Pharmacovigilance, Medical Researchers, Quality Control & Assurance Managers, Compliance and Regulatory Affairs Managers, Product Development Managers, Operations Directors, Drug Safety Practitioners, Risk Management Officers, Public Health Officers
To immediately book your place at this acclaimed course, send us the completed and signed registration herewith attached to email@example.com. We look forward to confirming your participation.